MDL Mass Tort & Class Action Monitor
Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
SEARCH THE ARCHIVES
Issue #15, February 2018
Aetna Inc. and its affiliates have been sued in California federal court following recent revelations that the insurer is under investigation for improperly denying claims for treatment that it said were not medically necessary.
Issue #14, January 2018
A California state court judge has designated San Francisco as the centralized venue for all pending and future lawsuits filed against electric utility PG&E Corporation for its alleged role in the recent Northern California wine country wildfires.
Plaintiffs have filed a motion with the Judicial Panel on Multidistrict Litigation seeking a centralized pre-trial docket for all federal lawsuits targeting Intel processors and their alleged susceptibility to security breaches.
The judge overseeing the National Prescription Opiate MDL docket has granted a motion to approve a leadership structure and several leadership positions proposed by plaintiffs’ counsel representing parties in the litigation.
Plaintiffs who sued Apple Inc. in federal court claiming that the tech giant released an update in early 2017 that reduced the performance of their iPhones have filed a motion requesting that the cases be consolidated before a single judge.
Issue #12, November 2017
The parties in 42 pending Abilify compulsive behavior cases have asked a New Jersey state court to classify the actions as a multi-county litigation for centralized management, arguing that the litigation involves common, recurrent issues of law and fact.
Martin P. Schrama and Stefanie Colella-Walsh of Stark & Stark discuss recent decisions involving federal multi-state class actions in the wake of the U.S. Supreme Court's personal jurisdiction ruling in Bristol-Myers Squibb Co. v. Superior Court.
A Louisiana federal judge has refused to dismiss a Chinese drywall class action, ruling that the U.S. Supreme Court’s recent decision in Bristol-Myers Squibb Co. v. Superior Court of California does not divest the court of personal jurisdiction over the non-resident defendants because the precedent set by the high court does not apply to class actions.
Companies accused in numerous federal lawsuits of failing to warn that their warming device poses a risk of infection during surgery have asked a federal judicial panel to transfer all of the cases to South Carolina for pre-trial coordination.
Issue #11, October 2017
Plaintiffs who allege they suffered heart failure after taking Onglyza and Kombiglyze (Saxagliptin) have filed a motion with the Judicial Panel on Multidistrict Litigation, requesting that a centralized docket be established in California for all federal lawsuits involving the Type 2 diabetes drugs.